# A Study of Bomedemstat (IMG-7289/MK-3543) in Participants With Polycythemia Vera (IMG-7289-CTP-203/MK-3543-004)

> **NCT05558696** · PHASE2 · COMPLETED · sponsor: **Imago BioSciences, Inc., a subsidiary of Merck & Co., Inc., (Rahway, New Jersey USA)** · enrollment: 20 (actual)

## Conditions studied

- Polycythemia Vera

## Interventions

- **DRUG:** Bomedemstat

## Key facts

- **NCT ID:** NCT05558696
- **Lead sponsor:** Imago BioSciences, Inc., a subsidiary of Merck & Co., Inc., (Rahway, New Jersey USA)
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-09-07
- **Primary completion:** 2025-03-24
- **Final completion:** 2025-07-10
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2026-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05558696

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05558696, "A Study of Bomedemstat (IMG-7289/MK-3543) in Participants With Polycythemia Vera (IMG-7289-CTP-203/MK-3543-004)". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT05558696. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*